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Response to ‘Statement from the European Society of Vascular Surgery and
the World Federation of Vascular Surgery Societies’
Inter-Society Consensus Document (TASC) III and International Standards for Vascular Care (ISVaC)
L. Norgren a,*, W.R. Hiatt b, M.R. Jaff c
a Örebro University Hospital, S 70185, Örebro, Sweden
b University of Colorado School of Medicine, Denver, Colorado, USA
c Harvard Medical School, Boston, Massachusetts, USAAs co-editors and chair of the steering committee for TASC
III we would like to respond to the announcements from
the SVS and ESVS published in your respective journals on
their intent to develop a new global vascular practice
guideline. Speciﬁcally the TASC process and intentions have
been misrepresented by both societies and we would like
the opportunity to provide our perspective on the events
that have transpired over the past several years.
The original TASC publication in 2000 and the TASC II
update in 2007 were developed on the same model of an
interdisciplinary representation of mainly North American
and European vascular societies; however TASC II removed
the ‘TransAtlantic’ preﬁx as we included vascular societies
from Asia, South Africa and Australia. TASC IIb was devel-
oped in 2009 as an intermediate version, intended to be a
focused update on the TASC lesion classiﬁcation, while
planning for TASC III. Objections were raised by the surgical
societies speciﬁcally on the recommendation for an ‘endo-
vascular-ﬁrst’ approach for a majority of lesions. As co-
editors we attempted to resolve those concerns but were
not successful. As a result and speciﬁcally to keep all
vascular societies at the table, we decided to not publish
TASC IIb at that time and rather move the discussions into
TASC III, to which the surgical societies were fully
committed.
TASC III was launched in 2010 with authors and chap-
ters proposed in 2011 including a representative mix of
authors, vascular societies and countries involved. How-
ever over 2 years ago the surgical societies raised con-
cerns as indicated in the documents published in the
EJVES and JVS about process, industry involvement and
transparency (ESVS), governing the guidelines process,
conﬂict of interest polices, bias and evidence, and global
representation of the guidelines (SVS). For each of those
points we attempted to accommodate the concerns.
Speciﬁcally the surgical societies requested an expanded
independent steering committee which we assembled,
composed of 2 surgical (SVS, ESVS), 2 interventionalDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2013.11.009
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http://dx.doi.org/10.1016/j.ejvs.2014.02.010radiology and 2 medical (1 vascular medicine, 1 cardiol-
ogy) members. The TASC III steering committee charter,
ratiﬁed by all members, included a process to deal with all
aspects of disclosure of relationships with industry,
composition of writing groups to avoid bias and alignment
with contemporary reporting standards. Writing group
members were elected by the societies, which are to
accept and formally endorse the guidelines to secure the
oversight of the process. The charter describes the
method for evidence grading and classiﬁcation of recom-
mendations (a hybrid of GRADE and ACC/AHA grading
systems). The SVS statement that the guidelines need to
be truly global has indeed been met by TASC III, including
Europe, North America, Australia, Latin America, Japan,
South Africa, India, China, the Gulf States and Israel.
Despite these improvements in the TASC process, the
negotiations broke down when the surgical societies
requested 50% control of the steering committee. As noted
by the ESVS the justiﬁcation for this level of representation
is that “Setting standards across the world for optimal care
of this group of patients resides principally with vascular
surgeons.” Unfortunately we could not support this unilat-
eral and somewhat hegemonic approach. TASC has always
been a fully collaborative process resulting in a document
that has not been dominated by any particular society or
interest. In fact if a real conﬂict of interest existed, ceding
control of any global vascular guideline document to a
single discipline would be inherently conﬂicted and not
representative. In addition during the planning stage, out of
50 invited authors of TASC III, 23 were surgeons, a fact the
authors of the EJVES and SVS statements should have been
aware given our extensive communications.
We also want to express our extreme disappointment in
the surgical society withdrawal. That action is not in the
best interest of our patients as clinical vascular care is
inherently inter-disciplinary. Innovations and optimal care
delivery require a deeply collaborative approach and we
feel that spirit has now been compromised.
